The largest database of trusted experimental protocols

Paravision 7

Manufactured by Bruker
Sourced in Germany

ParaVision 7 is a comprehensive software platform designed for MRI data acquisition, processing, and analysis. It provides a user-friendly interface for controlling and configuring Bruker MRI systems, enabling researchers to efficiently manage their experimental workflows.

Automatically generated - may contain errors

2 protocols using paravision 7

1

Multi-Modal MRI of Glioblastoma Tumor

Check if the same lab product or an alternative is used in the 5 most similar protocols
MRI was performed on a 7 Tesla scanner (Bruker PharmaScan, Billerica, MA) operated by ParaVision 7 with a quadrature RF coil for signal transmission and reception. T2-weighted images were acquired at the axial direction using a TuborRARE sequence with the following parameters: TR/TE = 4200/48 ms, RARE factor = 8, Averaging = 4, Matrix size = 256 × 192, FOV = 20 × 20 mm2, slice number = 21, slice thickness = 0.5 mm. T1-weighted MRI was performed using a MDEFT sequence with 4 segments, segment TR = 2600 ms, TE = 2.2 ms, TI = 950 ms, flip angle = 30°, Averaging = 3, Matrix = 256 × 256, FOV = 20 × 20 mm2, slice number = 15, slice thickness = 0.5 mm. The T1- and T2-weighted MRI was followed by tail vein injection of gadolinium (MultiHance, Bracco Diagnostics) at 0.1 mmol/kg. After 15 min of gadolinium injection, the mouse was scanned using T1- and T2-weighted MRI again. Mice were anesthetized using 1.5% isoflurane carried by 1 L/min oxygen. The breathing rate and body temperature were monitored during scanning. The isoflurane was continuously adjusted to maintain the breathing rate between 40 and 80 bpm.
Region-of-interest (ROI) analysis in image J (imagej.nih.gov/ij/) was used to measure tumor volumes. The post-contrast T1-weighted images (T1post) were primarily used for the measurements with pre-contrast T1-weighted (T1pre) and T2-weighted images as references.
+ Open protocol
+ Expand
2

Multiparametric MRI Analysis of Brain Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
The FA and ADC were calculated using ParaVision 7 (PharmaScan 70/16 US; Bruker BioSpin, Ettlingen, Germany). The NODDI parameters, including the ICVF, ISO, and ODI, were calculated using MATLAB (MathWorks, Natick, MA, USA) [40 (link),41 (link)]. Analyses and calculations for APT imaging were performed using MATLAB (MathWorks) [40 (link),41 (link)]. The MTR asymmetry (MTR value) was calculated using the following equation: MTRasym(%) = (S[−αppm] − S[+αppm])/S0. The APT CEST signal was defined as an MTR asymmetry of +3.5 ppm. The MTR asymmetry is expressed as the mean ± standard deviation (SD). All the T2WI signal intensity ratios and MTR, ADC, FA, ICVF, ODI, and ISO values were measured using ImageJ 1.53a (National Institutes of Health, Bethesda, MD, USA). The ROIs were placed around the entire tumor excluding hemorrhage and necrosis based on T2WI and ADC maps (Figure 2). The tumor volume was defined as the total area of all the T2WIs showing the tumor multiplied by the slice thickness of 1.0 mm. The T2 signal intensity ratio was calculated as the ratio of the mean signal value of the tumor in the solid ROI to the mean signal value of the contralateral normal brain tissue in the dotted ROI (Figure 2).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!